Detalhe da pesquisa
1.
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trials.
J Neurol Neurosurg Psychiatry
; 2024 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38383156
2.
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.
J Neurol Neurosurg Psychiatry
; 95(2): 142-150, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37775266
3.
Influence of cognition on the correlation between objective and subjective upper limb measures in people with multiple sclerosis.
Neurol Sci
; 45(6): 2783-2789, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38175316
4.
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
J Neurol Neurosurg Psychiatry
; 94(4): 290-299, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36522154
5.
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Mult Scler
; 29(7): 856-865, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37165941
6.
Correlation between patient-reported manual ability and three objective measures of upper limb function in people with multiple sclerosis.
Eur J Neurol
; 30(1): 172-178, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36086993
7.
Brain and cognitive reserve mitigate balance dysfunction in multiple sclerosis.
Neurol Sci
; 44(12): 4411-4420, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37464205
8.
Evaluation of mild-to-moderate COVID-19 through dual-task paradigm: a longitudinal case-controlled study.
Neurol Sci
; 44(12): 4167-4177, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37880453
9.
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.
Int J Mol Sci
; 24(10)2023 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37239872
10.
Shift of multiple sclerosis onset towards older age.
J Neurol Neurosurg Psychiatry
; 2022 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35477891
11.
Multidomain and long-term cognitive evaluation in malignant glioma patients.
Future Oncol
; 18(15): 1839-1848, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35196869
12.
Recurrent glioblastoma: which treatment? A real-world study from the Neuro-oncology Unit "Regina Elena" National Cancer Institute.
Neurol Sci
; 43(9): 5533-5541, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35641731
13.
Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression.
Mult Scler
; 27(9): 1391-1402, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33104449
14.
'Posture second' strategy predicts disability progression in multiple sclerosis.
Mult Scler
; 27(7): 1140-1144, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33045924
15.
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.
Mult Scler
; 27(3): 331-346, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32940121
16.
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.
Mult Scler
; 27(3): 347-359, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32940128
17.
Ozone-induced encephalopathy: A novel iatrogenic entity.
Eur J Neurol
; 28(8): 2471-2478, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33657263
18.
Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD score.
Eur J Neurol
; 28(8): 2533-2542, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33786942
19.
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Eur J Neurol
; 28(4): 1299-1307, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33305459
20.
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 91(3): 271-277, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31974130